A central IRB review process allows for multiple study sites in a multi-center trial to rely on the review of a single (i.e. central) IRB, rather than using multiple IRBs affiliated with each ...

OCALA, Fla., April 04, 2023 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (AIM) (“AIM” or the “Company”), an immuno-pharma company focused on the research and development of therapeutics to ...

A central IRB review process allows for multiple study sites in a multi-center trial to rely on the review of a single IRB, rather than using multiple IRBs affiliated with each individual research ...

SciTech Development ("SciTech" or the "Company"), a clinical-stage pharmaceutical company with a novel and patented drug delivery platform, today announced that the company has received IRB ...

Inventiva has lifted the voluntary pause on screening and randomization in the NATiV3 clinical trial following the approval from the US central IRB of the amended protocol and ICF. Screening of ...

The University considers an external IRB to be any IRB that is not the University IRB (i.e., the local IRB) including: Independent IRB: a review board that is not owned or operated by the research ...

San Diego, California--(Newsfile Corp. - January 27, 2023) - Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye" or the "Company"), a pharmaceutical company developing a proprietary, synthetic cannabinoid ...

OCALA, Fla., April 04, 2023 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), an immuno-pharma company focused on the research and development of ...

San Diego, California--(Newsfile Corp. - January 27, 2023) - Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye" or the "Company"), a pharmaceutical company developing a proprietary, synthetic cannabinoid ...

"The central IRB approval is another significant clinical milestone toward our phase 2 initiation in the US as we also continue enrollment in our on-going phase 1 study in Australia." SBI-100 OE is a ...

Skye Bioscience Inc (OTCQB:SKYE) told investors that its Phase 2 clinical trial protocol has received study-level approval from a central institutional... This website uses cookies We use cookies to ...